Free tool
Medicare drug spending
Last checked: Nov 20, 2026Latest source record: 2024 calendar yearSource: CMS (Medicare Part D Spending by Drug : 2024-01-01; Medicare Part B Spending by Drug : 2024-01-01)Methods & limitations
Part D, 2024
$288.7B
Gross drug spending in the dataset
Part B, 2024
$60.8B
Gross drug spending in the dataset
Drugs listed
20
Part D and Part B
Total spending by year
- Part D
- Part B
View as table
| Year | Part D | Part B |
|---|---|---|
| 2020 | $194,092,038,339 | $37,778,829,680 |
| 2021 | $213,513,349,361 | $40,135,340,775 |
| 2022 | $239,779,215,689 | $44,241,259,745 |
| 2023 | $275,808,918,753 | $50,775,853,083 |
| 2024 | $288,667,842,058 | $60,838,164,403 |
Top 20 by total spending
2024 figures. Growth compares with 2023. Per-beneficiary ranks skip drugs with fewer than 11 beneficiaries.
| Drug | Part | Spending | Change | Beneficiaries | Per beneficiary | Per unit |
|---|---|---|---|---|---|---|
| Tymlos Abaloparatide | D | $258M | +30% | 16,530 | $15,586 | $1,690.96 |
| Pregabalin Pregabalin | D | $199M | -31% | 1,493,012 | $133 | $0.31 |
| Lybalvi Olanzapine/Samidorphan Malate | D | $127M | +41% | 11,665 | $10,910 | $53.62 |
| Lyrica Pregabalin | D | $62.0M | -14% | 11,809 | $5,253 | $9.67 |
| Balversa Erdafitinib | D | $22.7M | +28% | 305 | $74,345 | $443.00 |
| Balsalazide Disodium Balsalazide Disodium | D | $18.7M | -21% | 23,921 | $781 | $0.48 |
| Cymbalta Duloxetine HCl | D | $15.9M | -12% | 4,512 | $3,521 | $8.98 |
| Trogarzo Ibalizumab-Uiyk | D | $12.4M | -12% | 107 | $115,873 | $1,096.33 |
| Cyanocobalamin Injection Cyanocobalamin (Vitamin B-12) | D | $4.6M | +101% | 115,345 | $40 | $2.98 |
| Cyanocobalamin Injection* Cyanocobalamin (Vitamin B-12)* · J3420 | B | $1.9M | -23% | 365,260 | $5 | $1.24 |
| Trogarzo Ibalizumab-Uiyk · J1746 | B | $1.6M | -4% | 19 | $82,264 | $74.12 |
| Pregabalin ER Pregabalin | D | $1.6M | -22% | 1,257 | $1,238 | $5.86 |
| Xofluza Baloxavir Marboxil | D | $1.2M | +22% | 7,548 | $166 | $158.92 |
| Lyrica Cr Pregabalin | D | $311K | -23% | 76 | $4,097 | $15.61 |
| Colazal Balsalazide Disodium | D | $175K | -11% | 12 | $14,599 | $6.29 |
| Balziva Norethindrone-Ethin. Estradiol | D | $40K | -23% | 231 | $175 | $0.74 |
| Balcoltra Levonorgest/Eth.Estradiol/Iron | D | $15K | -60% | 12 | $1,280 | $9.46 |
| Bss Balanced Salt Irrig Soln No.2 | D | $3K | -49% | 41 | $82 | $0.61 |
| Dodex Cyanocobalamin (Vitamin B-12) | D | $2K | -96% | 113 | $15 | $3.36 |
| Hydroxocobalamin Hydroxocobalamin · J3425 | B | $34 | n/a | 142 | $0 | $0.03 |
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.